Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study

NCT06563193 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2024-08-20

No results posted yet for this study

Summary

Overactive bladder is a prevalent urological disorder marked by symptoms such as urinary urgency, increased frequency of urination, and nighttime urination (nocturia). Neurotrophins, including nerve growth factor and brain-derived neurotrophic factor, play crucial roles in the development and function of neurons. Recent research has suggested a possible connection between these neurotrophins and OAB.

This study sought to explore the relationship between urinary levels of NGF and BDNF and the presence of OAB.

Conditions

Interventions

DIAGNOSTIC_TEST

NERVE GROWTH FACTOR

urinary neurotrophins

Sponsors & Collaborators

  • Erzincan Binali Yildirim Universitesi

    lead OTHER

Principal Investigators

  • Ozgur EKICI · ErzincanBinaliYildirim

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-15
Primary Completion
2025-05-01
Completion
2025-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06563193 on ClinicalTrials.gov